These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10572546)

  • 21. Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality.
    Tabár L; Vitak B; Chen HH; Yen MF; Duffy SW; Smith RA
    Cancer; 2001 May; 91(9):1724-31. PubMed ID: 11335897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer survival rates with mammographic screening: similar favorable survival rates for women younger and those older than 50 years.
    Thurfjell EL; Lindgren JA
    Radiology; 1996 Nov; 201(2):421-6. PubMed ID: 8888234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammographic screening for breast cancer in women under fifty: a review.
    Ewart RM
    Nebr Med J; 1992 Dec; 77(12):330-5. PubMed ID: 1480253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mammographic screening in older women. Is it worthwhile?
    van Dijck JA; Broeders MJ; Verbeek AL
    Drugs Aging; 1997 Feb; 10(2):69-79. PubMed ID: 9061265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should we recommend screening mammography for women aged 40 to 49?
    Esserman L; Kerlikowske K
    Oncology (Williston Park); 1996 Mar; 10(3):357-64; discussion: 370-6. PubMed ID: 8820449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast-cancer screening with mammography in women aged 40-49 years. Swedish Cancer Society and the Swedish National Board of Health and Welfare.
    Int J Cancer; 1996 Dec; 68(6):693-9. PubMed ID: 8980168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Assessment of mammography screening and its introduction in Germany in the Statutory Early Diagnosis Program].
    von Fournier D
    Zentralbl Gynakol; 1999; 121(3):159-65. PubMed ID: 10209861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
    Pace LE; Keating NL
    JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit of screening mammography in women aged 40-49: a new meta-analysis of randomized controlled trials.
    Hendrick RE; Smith RA; Rutledge JH; Smart CR
    J Natl Cancer Inst Monogr; 1997; (22):87-92. PubMed ID: 9709282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades.
    Tabár L; Vitak B; Chen TH; Yen AM; Cohen A; Tot T; Chiu SY; Chen SL; Fann JC; Rosell J; Fohlin H; Smith RA; Duffy SW
    Radiology; 2011 Sep; 260(3):658-63. PubMed ID: 21712474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of screening mammography. A meta-analysis.
    Kerlikowske K; Grady D; Rubin SM; Sandrock C; Ernster VL
    JAMA; 1995 Jan; 273(2):149-54. PubMed ID: 7799496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer screening outcomes in women ages 40-49: clinical experience with service screening using modern mammography.
    Sickles EA
    J Natl Cancer Inst Monogr; 1997; (22):99-104. PubMed ID: 9709284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening younger women at risk for breast cancer.
    Vogel VG
    J Natl Cancer Inst Monogr; 1994; (16):55-60. PubMed ID: 7999470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Stockholm Mammographic Screening Trial: Risks and benefits in age group 40-49 years.
    Frisell J; Lidbrink E
    J Natl Cancer Inst Monogr; 1997; (22):49-51. PubMed ID: 9709275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.
    Humphrey LL; Helfand M; Chan BK; Woolf SH
    Ann Intern Med; 2002 Sep; 137(5 Part 1):347-60. PubMed ID: 12204020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Breast cancer screening in the older woman: an effective way to reduce mortality?
    Paesmans M; Ameye L; Moreau M; Rozenberg S
    Maturitas; 2010 Jul; 66(3):263-7. PubMed ID: 20451335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A meta-analysis of mammographic screening with and without clinical breast examination.
    Hamashima C; Ohta K; Kasahara Y; Katayama T; Nakayama T; Honjo S; Ohnuki K
    Cancer Sci; 2015 Jul; 106(7):812-8. PubMed ID: 25959787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer screening. Interpreting new data for clinical practice.
    Daly L
    Physician Assist; 1994 Oct; 18(10):47-51, 56, 61-6. PubMed ID: 10138304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National Institutes of Health Consensus Development Conference Statement: Breast Cancer Screening for Women Ages 40-49, January 21-23, 1997. National Institutes of Health Consensus Development Panel.
    J Natl Cancer Inst; 1997 Jul; 89(14):1015-26. PubMed ID: 9230883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Risk-benefit analysis for mass screening of breast cancer utilizing mammography as a screening test].
    Iinuma TA; Tateno Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Sep; 49(9):1091-5. PubMed ID: 2587191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.